IgE Food Allergens Screen

$650.00

20 food allergen screen

In stock

SKU: NR-R10402 Category:

Description

Food Allergen List

1 Egg white (f1)

2 Egg yolk (f75)

3 Cow’s milk (f2)

4 Wheat flour (f4)

5 Beef (f27)

6 Chicken (f83)

7 Peanut (f13)

8 Hazelnut (f17)

9 Almond (f20)

10 Soybean (f14)

11 Tomato (f25)

12 Carrot (f31)

13 Potato (f35)

14 Onion (f48)

15 Celery (f85)

16 Apple (f49)

17 Codfish (f3)

18 Salmon (f41)

19 Shrimp (f23)

20 CCD (o214)

Related Products:

IgE Food Allergens Screen

IgG4 Food Antigen/Allergen Screen ELISA (88 Antigens)

Total Human IgE ELISA Test Kit

Human ovalbumin specific IgE,OVA sIgE ELISA Kit




Data Sheet

Application IgE Food Allergens kit has been designed for the detection of specific
allergen-related IgE antibodies in serum and plasma. Further applications in other body fluids are
possible
Assay principle IgE Food Allergens kit is based on the principle of the enzyme immunoassay. 16 patients
can be tested with each kit. One test strip is required per patient. On each individual strip 20 different
allergens including CCD for the detection of antibodies of low clinical relevance and a control line for
test evaluation are coated in parallel lines. Following a pre-wetting step the strips are incubated with
patient serum. A binding between the IgE antibodies of the serum and the immobilized allergens takes
place. After 60 minutes incubation at room temperature, the strips are rinsed with diluted wash solution,
in order to remove unbound material. Then ready-to-use anti-human-IgE-AP conjugate is added and
incubated for another 30 minutes at room temperature. After a further washing step, the substrate
(BCIP/NBT) solution is pipetted and incubated for 30 minutes at room temperature, inducing the
development of a precipitating dye on the lines in the case of positive reactions. The color development
is terminated by rinsing the strips with wash solution. The concentration of the IgE antibodies is directly
proportional to the intensity of the color
Background The existence of IgE in man as a unique class of immunoglobulins which are important in the mediation
of the allergic response has been known for over twenty years. The mechanism of action involves an
initial antigenic stimulation of immunocompetent B lymphocytes by a specific antigen, a process which
induces the lymphocyte to respond by producing specific antibody of several classes.
One class, reaginic or IgE antibody, becomes partially bound via its Fc portion to receptors on the
surface of mast cells end basophilic leukocytes. Upon further stimulation by specific allergens, these
cell-bound IgE molecules bind via their Fab portion to the allergen. This combination triggers the mast
cells and basophilic leukocytes to release various vasoactive amines into the blood and the surrounding
tissue. These substances cause smooth muscle constriction and lead ultimately to allergic conditions
such as wheal and flare reactions, hives, dermatitis, rhinitis, hay fever, asthma and anaphylactic shock.
IgE determinations are most valuable in the diagnostic assessment of patients with established or
suspected allergic disease. In normal subjects, IgE values are related to age, with normal values
peaking around 10-14 years. Infants and children with family history of atopic allergy are at increased
risk of developing disease and constitute a prime population for screening. Studies have shown that
conditions such as asthma, rhinitis, eczema, urticaria, dermatitis and some parasitic infections lead to
increased IgE levels. Asthma, hay fever and atopic eczema patients may produce levels 3-10 times
those of normal patients.
Circulating levels of total or allergen-specific IgE can be determined by the use of anti-human IgE or
specific allergens attached to a solid phase carrier. This approach uses an enzyme labelled antibody
towards IgE and is known as the enzyme allegro sorbent test (EAST).